Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €84.00 Price Target at Deutsche Bank AG

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €84.00 ($98.82) target price from analysts at Deutsche Bank AG in a research report issued on Tuesday, August 8th. The brokerage presently has a “neutral” rating on the stock.

Several other analysts also recently issued reports on FME. UBS AG set a €68.00 ($80.00) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “sell” rating in a report on Wednesday, May 3rd. Independent Research GmbH set a €88.00 ($103.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a report on Tuesday, August 8th. Berenberg Bank set a €92.10 ($108.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Monday, August 7th. Commerzbank Ag set a €88.00 ($103.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a report on Monday, August 7th. Finally, S&P Global set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, August 1st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of “Hold” and a consensus price target of €88.21 ($103.78).

Fresenius Medical Care AG & Co. KGaA (ETR FME) traded down 0.65% during mid-day trading on Tuesday, reaching €79.18. 316 shares of the company’s stock traded hands. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €70.82 and a 52-week high of €89.07. The company has a market capitalization of €24.30 billion and a price-to-earnings ratio of 20.42. The company has a 50-day moving average of €81.50 and a 200-day moving average of €81.20.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2017/08/19/fresenius-medical-care-ag-84-00-price-target-at-deutsche-bank-ag-updated.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit